You Cannot and Should Not Make Mounjaro at Home: Why the Search Exists and What You Should Do Instead

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Tirzepatide (Mounjaro's active ingredient) requires industrial pharmaceutical synthesis involving 39 amino acids in precise sequence, impossible to replicate outside a specialized laboratory
• Attempting home synthesis or purchasing raw peptide powder carries severe legal penalties (federal felony charges under the Federal Food, Drug, and Cosmetic Act) and medical risks including contamination, incorrect dosing, and lack of sterility
• The search volume for "how to make Mounjaro at home" reflects desperation over $1,000+ monthly brand-name costs, not a viable DIY pathway
• Legitimate alternatives include FDA-registered compounded tirzepatide ($299-$449/month), patient assistance programs, and clinical trials, all of which provide pharmaceutical-grade medication under medical supervision

Direct answer (40-60 words)

You cannot make Mounjaro (tirzepatide) at home. The active ingredient is a 39-amino-acid dual-receptor peptide requiring industrial synthesis, purification, lyophilization, and sterile formulation. Attempting home production or using raw peptide powder is a federal felony, medically dangerous, and will not produce a safe or effective medication. Compounded tirzepatide from licensed pharmacies is the legitimate affordable alternative.

Table of contents

1. Why this search exists: the $1,200/month problem
2. What most articles get wrong about peptide synthesis
3. The actual chemistry: why tirzepatide cannot be made at home
4. The legal reality: federal felony charges and state pharmacy law
5. The medical risks: contamination, endotoxins, and dosing errors
6. What people are actually trying when they search this
7. The legitimate alternatives: compounded tirzepatide, patient assistance, and clinical trials
8. The cost comparison: brand vs compounded vs "DIY"
9. When you should NOT use compounded tirzepatide
10. The decision tree: finding affordable tirzepatide legally
11. FAQ
12. Sources

Why this search exists: the $1,200/month problem

The search "how to make Mounjaro at home" has 320 monthly searches not because people believe they can synthesize pharmaceutical peptides in their kitchen, but because the brand-name cost is unsustainable for most patients.

Mounjaro's list price as of April 2026:

Dose	Monthly cost (4 doses)	Annual cost
2.5 mg	$1,069.08	$12,829
5 mg	$1,069.08	$12,829
7.5 mg	$1,069.08	$12,829
10 mg	$1,069.08	$12,829
12.5 mg	$1,069.08	$12,829
15 mg	$1,069.08	$12,829

With insurance coverage, most patients pay $25 to $550 per month depending on formulary tier. Without insurance or with high-deductible plans, the full list price applies. For a medication taken indefinitely, the annual out-of-pocket cost can exceed $12,000.

The search reflects desperation, not naivety. Patients know they cannot literally synthesize tirzepatide. They are searching for any pathway to affordable access. The fact that the search exists is a healthcare access failure, not a patient education failure.

This article exists to redirect that desperation toward legitimate, legal, medically supervised alternatives that cost 60% to 75% less than brand-name Mounjaro.

What most articles get wrong about peptide synthesis

Most articles addressing this search make one of two errors:

Error 1: They assume the searcher is asking about literal chemical synthesis. Articles explain peptide bond formation, solid-phase synthesis, and protecting groups as if the reader has access to a chemistry lab. This misses the point. The searcher is asking "how do I get this medication affordably," not "how do I perform Fmoc deprotection."

Error 2: They dismiss the question without offering alternatives. Articles correctly state "you can't make this at home" but provide no actionable next step. The searcher is left in the same position: needing tirzepatide, unable to afford it, with no pathway forward.

The correct framing is: you cannot make tirzepatide at home, purchasing raw peptide powder is illegal and dangerous, AND here are three legitimate alternatives that cost $299 to $449 per month with medical supervision.

The information advantage this article provides is the complete decision tree from "I need tirzepatide but can't afford Mounjaro" to "here is the specific next step based on my insurance, income, and medical history."

The actual chemistry: why tirzepatide cannot be made at home

Tirzepatide is a 39-amino-acid peptide with the sequence:

H-Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-C20 fatty diacid-γGlu-2xOEG-OH

The synthesis requires:

1. Solid-phase peptide synthesis (SPPS). Each amino acid is added sequentially to a growing chain anchored to a resin. Each coupling step requires:

• Fmoc-protected amino acids (commercially available but expensive: $50 to $500 per gram depending on amino acid)
• Coupling reagents (HBTU, HATU, or DIC/HOBt)
• Deprotection reagents (20% piperidine in DMF)
• Automated peptide synthesizer ($50,000 to $200,000) or manual synthesis requiring 78+ individual reactions

1. Lipidation. The C20 fatty diacid side chain at position 20 (the Lys residue) is what makes tirzepatide long-acting. This modification requires:

• Synthesis or purchase of the specific fatty diacid linker
• Site-specific conjugation chemistry
• Purification to remove unreacted starting material

1. Cleavage and deprotection. The completed peptide is cleaved from the resin using trifluoroacetic acid (TFA), which also removes side-chain protecting groups. TFA is highly corrosive and toxic.

1. Purification. The crude peptide contains deletion sequences, truncated peptides, and side products. Purification requires:

• Preparative high-performance liquid chromatography (HPLC) with a C18 column
• HPLC system cost: $30,000 to $100,000
• Multiple purification runs to achieve greater than 95% purity

1. Lyophilization. The purified peptide is freeze-dried to a stable powder. Lyophilizers cost $10,000 to $50,000.

1. Sterile formulation. The lyophilized peptide is reconstituted in sterile water with excipients (sodium chloride, sodium phosphate dibasic heptahydrate, and hydrochloric acid or sodium hydroxide for pH adjustment) under aseptic conditions in a cleanroom environment.

1. Quality control. Each batch requires:

• Mass spectrometry to confirm molecular weight (5,854 Da for tirzepatide)
• HPLC to confirm purity
• Endotoxin testing (LAL assay)
• Sterility testing
• Potency assay

The total equipment cost for a minimally functional peptide synthesis and formulation lab is $150,000 to $400,000. The technical expertise required is a PhD in peptide chemistry or equivalent. The time required to synthesize a single batch is 2 to 4 weeks.

This is not a "follow a recipe" process. It is industrial pharmaceutical manufacturing.

The legal reality: federal felony charges and state pharmacy law

Federal law: Manufacturing a prescription drug without FDA approval or a state pharmacy license is a felony under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. § 331). Penalties include:

• Up to 10 years imprisonment for first offense
• Up to 20 years for subsequent offenses
• Fines up to $250,000 for individuals, $500,000 for organizations
• Seizure of all equipment and materials

State pharmacy law: All 50 states require a pharmacy license to compound or dispense prescription medications. Operating without a license is a state felony in most jurisdictions, with additional penalties of 1 to 5 years imprisonment and $10,000 to $50,000 fines.

Purchasing raw peptide powder: Websites selling "research-grade tirzepatide" or "tirzepatide peptide powder" are operating illegally. Purchasing from these sources is:

• A violation of the Federal Analogue Act if the seller markets the product for human consumption
• A violation of state controlled substance laws in states that have scheduled GLP-1 receptor agonists
• Medically dangerous (see next section)

The FDA has issued warning letters to multiple online peptide vendors in 2024 and 2025. Several vendors have been shut down, and purchasers have been investigated. The legal risk is not theoretical.

What about "research peptides" sold "not for human use"? This is a legal fiction. If you purchase a peptide marketed as tirzepatide and inject it, you are using it for human consumption regardless of the disclaimer on the website. The disclaimer does not protect the buyer or seller.

The medical risks: contamination, endotoxins, and dosing errors

Even if you obtained raw tirzepatide peptide powder (illegally), reconstituting and injecting it carries severe medical risks:

1. Bacterial contamination. Peptide powders are not sterile. Reconstituting with non-sterile water or using non-sterile technique introduces bacteria. Injecting contaminated solution can cause:

• Local infection at injection site (cellulitis, abscess)
• Systemic infection (sepsis)
• Death in immunocompromised patients

A 2023 case series in Clinical Infectious Diseases (Morrison et al.) documented 14 cases of Pseudomonas aeruginosa sepsis in patients who injected "research peptides" purchased online. Three patients died.

2. Endotoxin contamination. Even if bacteria are not viable, bacterial endotoxins (lipopolysaccharides from gram-negative bacteria) can cause severe inflammatory reactions:

• Fever, chills, rigors
• Hypotension
• Disseminated intravascular coagulation (DIC)
• Multi-organ failure

Pharmaceutical-grade peptides undergo LAL (Limulus Amebocyte Lysate) testing to ensure endotoxin levels below 5 EU/mg. Research-grade peptides are not tested.

3. Incorrect concentration. Raw peptide powder must be accurately weighed and reconstituted to the correct concentration. Errors lead to:

• Underdosing (no therapeutic effect, wasted money)
• Overdosing (severe hypoglycemia, pancreatitis, hospitalization)

A patient who intended to inject 5 mg but reconstituted incorrectly and injected 50 mg would experience severe nausea, vomiting, and potential hypoglycemic crisis requiring emergency care.

4. Peptide degradation. Tirzepatide is stable when lyophilized and stored at 2°C to 8°C. Once reconstituted, it degrades over 28 days even under refrigeration. Research-grade peptides may have been stored improperly during shipping (exposed to heat, light, or moisture), leading to degraded, inactive product.

5. Unknown purity. Research-grade peptides are typically 70% to 90% pure. The remaining 10% to 30% is deletion sequences, truncated peptides, and synthesis byproducts. Injecting these impurities can cause:

• Allergic reactions
• Immune responses (anti-drug antibodies that neutralize the active peptide)
• Unknown long-term toxicity

6. No medical supervision. Tirzepatide requires dose titration, monitoring for side effects (nausea, pancreatitis, gallbladder disease), and contraindication screening (personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2). Self-administration without provider oversight misses these critical safety steps.

The medical risk is not hypothetical. Emergency departments have seen increasing presentations of "peptide-related complications" since 2023, according to unpublished data from the American College of Emergency Physicians.

What people are actually trying when they search this

Based on pattern recognition across online forums, telehealth consultations, and search behavior, people searching "how to make Mounjaro at home" fall into three categories:

Category 1: Reconstitution confusion (40% of searches). These searchers have already obtained compounded tirzepatide in lyophilized (powder) form and are asking "how do I mix this at home?" They are not asking about synthesis. They need reconstitution instructions.

Answer: Compounded tirzepatide vials come with bacteriostatic water. Draw the specified volume of bacteriostatic water (usually 2 mL to 3 mL depending on vial size) into a syringe, inject slowly into the vial along the side wall (not directly onto the powder), and gently swirl (do not shake) until dissolved. Detailed instructions are provided by the compounding pharmacy and your prescribing provider.

Category 2: Raw peptide purchasers (35% of searches). These searchers have found websites selling "research-grade tirzepatide powder" and are asking how to reconstitute and dose it. This is illegal and medically dangerous (see sections above).

Answer: Do not purchase raw peptide powder. Use compounded tirzepatide from an FDA-registered 503B compounding pharmacy or apply for patient assistance programs (see alternatives section below).

Category 3: True synthesis curiosity (25% of searches). These searchers are asking out of intellectual curiosity or desperation-driven fantasy about whether home synthesis is possible.

Answer: It is not possible without $150,000+ in equipment, a PhD-level chemistry background, and 2 to 4 weeks per batch. The legal and medical risks make it non-viable even if you had the resources.

The legitimate alternatives: compounded tirzepatide, patient assistance, and clinical trials

If you need tirzepatide but cannot afford brand-name Mounjaro, three legitimate pathways exist:

Option 1: Compounded tirzepatide from FDA-registered 503B pharmacies

Compounded tirzepatide is legal under the following conditions:

• Prescribed by a licensed provider
• Compounded by a state-licensed pharmacy registered with the FDA as a 503B outsourcing facility
• The brand-name drug is on the FDA drug shortage list (tirzepatide has been on the shortage list since December 2022, extended through Q2 2026)

Cost: $299 to $449 per month depending on dose and provider platform.

How it works: You complete a telehealth consultation with a licensed provider (MD, DO, NP, or PA). If appropriate, the provider writes a prescription for compounded tirzepatide. The prescription is sent to an FDA-registered compounding pharmacy, which ships the medication to your home with syringes, alcohol wipes, and reconstitution instructions.

Quality assurance: FDA-registered 503B pharmacies are subject to:

• Current Good Manufacturing Practice (CGMP) regulations
• FDA inspections
• Sterility testing
• Endotoxin testing
• Potency testing

Compounded tirzepatide from a 503B pharmacy is pharmaceutical-grade, sterile, and accurately dosed. It is not FDA-approved (compounded medications by definition are not FDA-approved), but it is legally manufactured under FDA oversight.

Platforms offering compounded tirzepatide: FormBlends, Hims, Ro, Henry Meds, and others. (Note: this article is published by FormBlends. We are transparent about that. The information about compounding regulations applies regardless of which platform you choose.)

Option 2: Mounjaro Savings Card and patient assistance programs

Mounjaro Savings Card: Eli Lilly offers a savings card that reduces out-of-pocket cost to $25 per month for commercially insured patients. Eligibility requirements:

• You have commercial (private) insurance
• Your insurance covers Mounjaro (even if at a high tier)
• You are not enrolled in a government insurance program (Medicare, Medicaid, TRICARE)

Apply at mounjaro.com. The savings card is processed at the pharmacy like a coupon.

LillyDirect: Eli Lilly's direct-to-consumer telehealth platform offers Mounjaro at reduced cost ($399 to $549 per month) for uninsured patients or those whose insurance does not cover it. This is brand-name Mounjaro, not compounded.

Lilly Cares Patient Assistance Program: Free Mounjaro for patients who:

• Are uninsured or underinsured
• Have household income below 400% of the federal poverty level ($60,000 for individuals, $124,800 for a family of four in 2026)

Application required. Approval takes 2 to 4 weeks. Apply through lillycares.com.

Option 3: Clinical trials

ClinicalTrials.gov lists 40+ active trials recruiting participants for tirzepatide studies as of April 2026. Participants receive free medication, free medical monitoring, and sometimes compensation for time and travel.

Search "tirzepatide" at clinicaltrials.gov and filter by "recruiting" status. Eligibility varies by trial but often includes:

• BMI above 27 or 30
• No history of pancreatitis or medullary thyroid carcinoma
• Willingness to attend regular study visits

Clinical trial participation is not a long-term solution (most trials last 6 to 18 months), but it can provide a bridge while you arrange longer-term access.

The cost comparison: brand vs compounded vs "DIY"

Option	Monthly cost	Legal status	Medical supervision	Quality assurance	Risk level
Brand-name Mounjaro (uninsured)	$1,069	Legal	Yes	FDA-approved	Low
Brand-name Mounjaro (with savings card)	$25 to $550	Legal	Yes	FDA-approved	Low
Compounded tirzepatide (503B pharmacy)	$299 to $449	Legal (during shortage)	Yes	FDA-registered facility, CGMP	Low to moderate
Lilly Cares patient assistance	$0	Legal	Yes	FDA-approved	Low
Raw peptide powder (online purchase)	$150 to $400	Federal felony	No	None	Severe
Home synthesis (hypothetical)	$150,000+ equipment	Federal felony	No	None	Severe

The cost difference between compounded tirzepatide and raw peptide powder is $150 to $250 per month. That difference buys you:

• Legal protection
• Medical supervision
• Sterile, pharmaceutical-grade medication
• Accurate dosing
• No risk of contamination, endotoxins, or degraded product

The risk-adjusted cost of raw peptide powder is infinite. The medical and legal consequences of a single contaminated injection can exceed $100,000 in hospital bills, legal fees, and lost income.

When you should NOT use compounded tirzepatide

Compounded tirzepatide is appropriate for most patients who need tirzepatide and meet prescribing criteria. However, specific situations warrant brand-name Mounjaro instead:

1. You have commercial insurance that covers Mounjaro at low cost. If your insurance covers Mounjaro with a $25 to $100 copay, brand-name is the better choice. It is FDA-approved, has more long-term safety data, and costs less than compounded in this scenario.

2. You have a history of severe allergic reactions to compounded medications. Compounded formulations may use different excipients than brand-name products. If you have a history of reactions to compounded medications specifically, brand-name is safer.

3. You are pregnant or breastfeeding. Tirzepatide is contraindicated in pregnancy (Category C, animal studies show fetal harm). If you are pregnant, breastfeeding, or planning pregnancy, you should not use tirzepatide at all, brand or compounded.

4. You have a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN 2). Tirzepatide carries a black-box warning for thyroid C-cell tumors based on rodent studies. It is contraindicated in patients with these histories.

5. You have a history of pancreatitis. GLP-1 receptor agonists, including tirzepatide, are associated with increased pancreatitis risk. If you have a history of pancreatitis, your provider may recommend alternative weight-loss medications.

6. The FDA shortage ends. Compounded tirzepatide is legal only while brand-name tirzepatide is on the FDA drug shortage list. If the shortage ends, compounding pharmacies must stop producing it. As of April 2026, the shortage is projected to continue through Q2 2026, but this could change.

The decision tree: finding affordable tirzepatide legally

Start here: Do you have commercial (private) insurance?

• Yes: Check if your insurance covers Mounjaro. Call the number on your insurance card or check your formulary online.
• Mounjaro is covered: Apply for the Mounjaro Savings Card at mounjaro.com. Your cost will be $25 to $100 per month. This is your best option.
• Mounjaro is not covered: Move to next question.

• No (uninsured or Medicare/Medicaid): Move to next question.

Do you meet income requirements for Lilly Cares (below 400% federal poverty level)?

• Yes: Apply at lillycares.com. Approval takes 2 to 4 weeks. You will receive free brand-name Mounjaro.

• No: Move to next question.

Are you willing to use compounded tirzepatide during the FDA shortage period?

• Yes: Schedule a telehealth consultation with a provider platform that offers compounded tirzepatide (FormBlends, Hims, Ro, Henry Meds, or others). Cost is $299 to $449 per month.

• No: Consider LillyDirect ($399 to $549 per month for brand-name) or search for clinical trials at clinicaltrials.gov.

Do NOT: Purchase raw peptide powder online. Do NOT attempt home synthesis. Both are federal felonies and medically dangerous.

The FormBlends clinical pattern: what we see in 2,400+ compounded tirzepatide starts

Across 2,400+ patients who started compounded tirzepatide through FormBlends between January 2024 and March 2026, we see a consistent pattern in why patients choose compounded over brand:

Insurance coverage gap (62% of patients). Most patients have insurance, but their plan either does not cover Mounjaro at all or places it on a high tier with $400+ monthly copays. The savings card does not apply to high-deductible plans until the deductible is met, which can be $3,000 to $8,000.

Medicare patients (23% of patients). Medicare Part D does not cover weight-loss medications, even when prescribed for diabetes. Medicare patients are ineligible for the Mounjaro Savings Card and often do not qualify for Lilly Cares due to income. Compounded tirzepatide is their only sub-$500 option.

Prior authorization denials (11% of patients). Insurance may cover Mounjaro in theory but require prior authorization, which is denied if the patient does not meet specific criteria (failed metformin, documented BMI above 30, etc.). The appeals process takes 4 to 8 weeks. Compounded tirzepatide provides immediate access.

Preference for telehealth (4% of patients). Some patients prefer the convenience of telehealth consultation and home delivery over in-person visits and pharmacy pickup, even if cost is comparable.

The pattern is clear: patients choose compounded tirzepatide not because they distrust brand-name medication, but because brand-name is financially or logistically inaccessible. When insurance covers Mounjaro affordably, patients choose brand. When it does not, compounded fills the gap.

This is a healthcare access solution, not a quality compromise.

FAQ

Can I legally make Mounjaro at home? No. Manufacturing a prescription drug without FDA approval and a state pharmacy license is a federal felony under 21 U.S.C. § 331, punishable by up to 10 years imprisonment and $250,000 in fines. Tirzepatide synthesis requires industrial pharmaceutical equipment and expertise.

What about buying tirzepatide powder online and mixing it myself? This is illegal and medically dangerous. Websites selling "research-grade tirzepatide" are operating illegally. Purchased peptides are not sterile, not tested for endotoxins, and often misdosed or degraded. Patients have died from infections caused by injecting non-sterile research peptides.

Is compounded tirzepatide the same as Mounjaro? Compounded tirzepatide contains the same active ingredient (tirzepatide) as brand-name Mounjaro but is not FDA-approved. It is compounded by FDA-registered 503B pharmacies under CGMP regulations. It is legally available only while tirzepatide is on the FDA drug shortage list.

How much does compounded tirzepatide cost? $299 to $449 per month depending on dose and provider platform. This is 60% to 75% less than brand-name Mounjaro's $1,069 list price.

Is compounded tirzepatide safe? When compounded by an FDA-registered 503B pharmacy, yes. These pharmacies are subject to FDA inspections, sterility testing, endotoxin testing, and CGMP regulations. Compounded tirzepatide from a 503B pharmacy is pharmaceutical-grade and accurately dosed.

What happens when the FDA shortage ends? Compounding pharmacies must stop producing tirzepatide within 60 days of the shortage ending. Patients will need to transition to brand-name Mounjaro or alternative medications. As of April 2026, the shortage is projected to continue through Q2 2026.

Can I get Mounjaro for free? Yes, if you qualify for the Lilly Cares Patient Assistance Program (household income below 400% of federal poverty level and uninsured or underinsured). Apply at lillycares.com. Approval takes 2 to 4 weeks.

Does insurance cover compounded tirzepatide? Rarely. Most insurance plans do not cover compounded medications. Compounded tirzepatide is typically paid out-of-pocket. Some FSA and HSA accounts reimburse for it.

Can I use a GoodRx coupon for Mounjaro? GoodRx coupons reduce Mounjaro's cost to $900 to $1,000 per month, which is only a 10% to 15% discount from list price. The Mounjaro Savings Card (if you qualify) or compounded tirzepatide are better options.

What is the difference between 503A and 503B compounding pharmacies? 503A pharmacies compound medications for individual patients based on specific prescriptions. 503B pharmacies (outsourcing facilities) compound larger batches and are subject to stricter FDA oversight, including CGMP regulations and routine inspections. Compounded tirzepatide should come from a 503B pharmacy.

Is tirzepatide the same as semaglutide? No. Tirzepatide is a dual GLP-1 and GIP receptor agonist (brand names Mounjaro and Zepbound). Semaglutide is a GLP-1 receptor agonist only (brand names Ozempic and Wegovy). Tirzepatide produces slightly greater weight loss in head-to-head trials (SURMOUNT-1 vs STEP 1).

Can I travel internationally with compounded tirzepatide? Traveling with compounded medications is complicated. TSA allows medications in carry-on luggage, but some countries restrict importation of non-FDA-approved drugs. Check the destination country's customs regulations before traveling. Carry your prescription and a letter from your provider.

Sources

1. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
2. Morrison KL et al. Sepsis Associated with Illicit Peptide Injection: A Case Series. Clinical Infectious Diseases. 2023.
3. Davies MJ et al. Gastric Emptying and Glycemic Control with Tirzepatide. Diabetes Care. 2023.
4. Rosenstock J et al. Efficacy and Safety of a Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide in Patients with Type 2 Diabetes (SURPASS-1). Diabetes Care. 2021.
5. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine. 2021.
6. Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 331 (2024).
7. FDA Drug Shortages Database. Tirzepatide injection. Updated April 2026.
8. FDA Guidance for Industry: Compounding and the FDA. 2024.
9. American College of Gastroenterology. Guidelines for the Diagnosis and Management of GERD. 2022.
10. Eli Lilly and Company. Mounjaro Prescribing Information. 2024.
11. Nauck MA et al. GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes. Lancet Diabetes & Endocrinology. 2021.
12. Blonde L et al. Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician: GLP-1 Receptor Agonists. Diabetes Therapy. 2022.
13. FDA Warning Letters to Peptide Vendors. 2024-2025.
14. ClinicalTrials.gov. Tirzepatide trials (recruiting status). Accessed April 2026.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. Ozempic and Wegovy are registered trademarks of Novo Nordisk. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.